Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 310 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. The Tablo Console is a proprietary, compact, and mobile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for OM. Our analysts highlight strong fundamentals and favorable market sentiment, positioning OM for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: OM is a Strong Buy candidate.
OM stock price ended at $4.49 on 金曜日, after rising 4.42%
On the latest trading day Jun 12, 2026, the stock price of OM rose by 4.42%, climbing from $4.27 to $4.49. During the session, the stock saw a volatility of 10.00%, with prices oscillating between a daily low of $4.20 and a high of $4.62. Notably, trading volume dropped by 5.6K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 146.6K shares were traded, equating to a market value of approximately $83.2M.